首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

2126696

神經復健設備市場：依產品類型、適應症和地區分類

Neurorehabilitation Devices Market, By Product Type, By Indication, By Geography

出版日期: 2026年08月14日 | 出版商:

Coherent Market Insights | 英文 256 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2026年，神經復健設備市場規模將達29億美元，2033年將達72.1億美元。預計從2026年到2033年，該市場將以13.9%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	29億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	13.90%	2033年市場規模預測：	72.1億美元

該市場正在經歷重大的技術變革，主要促進因素包括神經系統疾病的日益普遍、中風和創傷性腦損傷的發生率不斷上升、對先進復健療法的需求不斷成長，以及機器人輔助復健、神經刺激、腦機介面和穿戴式復健技術的日益普及。

神經復健設備旨在幫助神經系統疾病患者恢復運動功能、活動能力、平衡能力、協調性、肌肉力量和生活自理能力。該市場涵蓋多種技術，例如穿戴式裝置、腦機介面、神經機器人系統和非侵入性刺激器，這些技術正擴大應用於中風、帕金森氏症、創傷性腦損傷、腦性麻痹和其他神經復健領域。

醫療專業人員越來越注重強化、重複和個人化的復健方法，以加速患者康復並減少對傳統手法治療的依賴。穿戴式復健機器人、機器人外骨骼、腦機介面和非侵入性電刺激技術的進步，使得以任務為導向的訓練、即時神經回饋和更個人化的復健方案成為可能。此外，復健治療模式從醫院轉向家庭和社區護理，也拓展了攜帶式、穿戴式式和數位連接的復健技術的應用潛力。

市場動態

由於神經系統疾病負擔日益加重，以及中風、帕金森氏症、創傷性腦損傷和其他神經病變患者對長期復原的需求不斷成長，市場呈現出強勁的成長動能。尤其中風領域需求特別突出，患者持續存在的步態、平衡、協調、肌肉力量和日常生活活動能力障礙，使得機器人復健、神經刺激、穿戴式裝置和其他運動功能恢復解決方案的需求顯著增加。

神經機器人技術、穿戴式復健系統、腦機介面和非侵入式刺激等領域的快速技術進步正進一步推動市場擴張。這些技術能夠實現可重複、可測量的復健訓練，同時提供神經回饋並支持個人化治療。此外，輕型復健機器人和穿戴式機器人系統正在創造機會，使康復的範圍超越傳統的固定設備和專門的康復設施。

進行性神經退化性疾病的日益普遍也加劇了對神經復健設備的長期需求。例如，帕金森氏症等疾病可能需要持續的復健治療，以支持患者的行走、平衡、運動控制、肌肉力量和獨立生活能力。隨著人口老化，神經系統疾病的負擔預計將進一步加重，導致需要復健治療的患者群體不斷擴大。

此外，市場正逐步向封閉回路型和多模態復健轉型，將腦機介面與機器人復健系統和即時神經回饋結合。同時，穿戴式慣性感測器、數位運動監測技術和家用復健設備的日益普及，使得即使在非臨床環境下，也能對患者的復健進展進行更客觀的評估。

由於北美擁有完善的復健基礎設施、活躍的神經科學研究、較早採用機器人和神經刺激技術，以及越來越多的專業復健中心，預計北美仍將是重要的區域市場。同時，亞太地區預計將實現最快的成長，這得益於復健服務的可及性提高、政府對輔助技術的日益重視以及數位化康復解決方案的日益普及。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對神經復健設備市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
神經復健設備市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用神經復健設備市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Bioness, Inc.
- Ectron Ltd.
- Hocoma AG
- Medtronic
- Tyromotion
- Agiliad
- Bioxtreme Robotics Rehabilitation
- St Jude Medical Inc.
- Alter G Inc.
- Denecor
- Ekso Bionics Holding Inc.
- Helius
- Interactive Motion Technologies
- Kinestica
- Kinetic Muscles
- Medtronic Plc.
- Neurostyle
分析師意見

第8章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI740

Neurorehabilitation Devices Market is estimated to be valued at USD 2.9 Bn in 2026 and is expected to reach USD 7.21 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2.9 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	13.90%	2033 Value Projection:	USD 7.21 Bn

The market is undergoing significant technological transformation, mainly driven by the rising prevalence of neurological disorders, increasing incidence of stroke and traumatic brain injuries, growing demand for advanced rehabilitation therapies, and wider adoption of robotic-assisted rehabilitation, neurostimulation, brain-computer interfaces, and wearable rehabilitation technologies.

Neurorehabilitation devices are designed to support recovery of motor function, mobility, balance, coordination, muscle strength, and functional independence among patients affected by neurological disorders. The market includes a diverse range of technologies such as wearable devices, brain-computer interfaces, neurorobotic systems, and non-invasive stimulators, which are increasingly being utilized across stroke, Parkinson's disease, traumatic brain injury, cerebral palsy, and other neurological rehabilitation settings.

Healthcare providers are increasingly focusing on intensive, repetitive, and personalized rehabilitation approaches to improve patient recovery and reduce dependence on conventional manual therapy. Advances in wearable rehabilitation robots, robotic exoskeletons, brain-computer interfaces, and non-invasive electrical stimulation are enabling task-oriented training, real-time neurological feedback, and more individualized rehabilitation programs. In addition, the growing transition from hospital-based rehabilitation toward home- and community-based care is expanding the potential application of portable, wearable, and digitally connected rehabilitation technologies.

Market Dynamics

The market is witnessing strong momentum owing to the rising burden of neurological disorders and the increasing requirement for long-term rehabilitation among patients with stroke, Parkinson's disease, traumatic brain injury, and other neurological disabilities. Stroke represents a particularly important demand area as persistent impairment in gait, balance, coordination, muscle strength, and activities of daily living creates substantial requirements for robotic rehabilitation, neurostimulation, wearable devices, and other motor-recovery solutions.

Rapid technological advancements in neurorobotics, wearable rehabilitation systems, brain-computer interfaces, and non-invasive stimulation are further supporting market expansion. These technologies enable repetitive and measurable rehabilitation exercises while providing neurological feedback and supporting personalized treatment. Lightweight rehabilitation robots and wearable robotic systems are also creating opportunities to extend rehabilitation beyond conventional stationary equipment and specialized rehabilitation facilities.

The rising prevalence of progressive neurodegenerative disorders is also strengthening long-term demand for neurorehabilitation devices. Conditions such as Parkinson's disease can require continuous rehabilitation to support walking, balance, movement control, muscle strength, and patient independence. Demographic ageing is expected to further increase the neurological disease burden and consequently expand the patient population requiring rehabilitation technologies.

The market is also gradually shifting toward closed-loop and multimodal rehabilitation, where brain-computer interfaces are integrated with robotic rehabilitation systems and real-time neurological feedback. At the same time, increasing adoption of wearable inertial sensors, digital movement-monitoring technologies, and home-based rehabilitation devices is enabling more objective assessment of patient recovery outside sophisticated clinical environments.

North America is expected to remain the dominant regional market, supported by established rehabilitation infrastructure, substantial neuroscience research activity, early adoption of robotic and neurostimulation technologies, and availability of specialized rehabilitation centers. Asia Pacific, meanwhile, is expected to register the fastest growth, supported by improving rehabilitation access, government attention toward assistive technologies, and increasing adoption of digital rehabilitation solutions.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Neurorehabilitation Devices Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bioness, Inc., Ectron Ltd., Hocoma AG, Medtronic, Tyromotion, Agiliad, Bioxtreme Robotics Rehabilitation, St Jude Medical Inc., Alter G Inc., Denecor, Ekso Bionics Holding Inc., Helius, Interactive Motion Technologies, Kinestica, Kinetic Muscles, Medtronic Plc., and Neurostyle.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Neurorehabilitation Devices Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Neurorehabilitation Devices Market

Market Segmentation

By Product Type (Revenue, USD Bn, 2021-2033)
Wearable Devices
Brain computer Interface
Neurorobotic System
Non-invasive Stimulators
By Indication (Revenue, USD Bn, 2021-2033)
Parkinson's Disease
Stroke
Traumatic Brain Injury
Cerebral Palsy
By Region (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
Bioness, Inc.
Ectron Ltd.
Hocoma AG
Medtronic
Tyromotion
Agiliad
Bioxtreme Robotics Rehabilitation
St Jude Medical Inc.
Alter G Inc.
Denecor
Ekso Bionics Holding Inc.
Helius
Interactive Motion Technologies
Kinestica
Kinetic Muscles
Medtronic Plc.
Neurostyle

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Indication
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Neurorehabilitation Devices Market, By Product Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Wearable Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Brain computer Interface
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Neurorobotic System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Non-invasive Stimulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Global Neurorehabilitation Devices Market, By Indication, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Parkinson's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Stroke
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Traumatic Brain Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Cerebral Palsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Neurorehabilitation Devices Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Bioness, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Ectron Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Hocoma AG
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Medtronic
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Tyromotion
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Agiliad
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Bioxtreme Robotics Rehabilitation
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- St Jude Medical Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Alter G Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Denecor
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Ekso Bionics Holding Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Helius
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Interactive Motion Technologies
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Kinestica
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Kinetic Muscles
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Medtronic Plc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Neurostyle
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views